Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights

Why did Coinbase join the S&P 500? How will US-China tariff rollback impact markets? What caused Amazon to partner with FedEx? Why are pharmaceutical stocks sliding today? How will Trump’s drug price order affect pharma? Why did Dow surge after US-China tariff deal? What are the implications of Nissan’s job cuts? How did US-China trade truce impact oil prices? Why is McDonald’s hiring 375,000 workers this summer?

Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights

benzinga.com/general/biotech/25/05/45358050/nano-cap-neurosense-therapeutics-gets-14-price-forecast-as-primec-nears-key-als-milestones

Last Wednesday, NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) said it scaled up its production of PrimeC to a commercial scale.
PrimeC, NeuroSense’s lead drug candidate, is a novel extended-release oral formulation with a unique fixed-dose combination of two FDA-approved drugs:…

This story appeared on benzinga.com, 2025-05-12 19:08:07.